First Header Logo Second Header Logo

Kevin High

Concepts (452)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Aging
25
2019
883
3.620
Why?
Geriatrics
11
2019
94
2.340
Why?
Geriatric Assessment
7
2019
356
1.390
Why?
Communicable Diseases
5
2009
19
1.260
Why?
Aged
41
2019
9538
1.090
Why?
HIV Infections
5
2015
371
1.040
Why?
Humans
69
2019
29396
0.910
Why?
Community-Acquired Infections
5
2005
31
0.840
Why?
Air Ambulances
2
2016
10
0.820
Why?
Biomedical Research
7
2017
155
0.760
Why?
Herpes Zoster
3
2009
9
0.710
Why?
Interleukin-23
4
2014
14
0.700
Why?
Dendritic Cells
2
2010
61
0.690
Why?
Respiratory Tract Infections
4
2012
41
0.690
Why?
Fever of Unknown Origin
2
2009
9
0.680
Why?
Patient Care Planning
1
2019
53
0.650
Why?
Frail Elderly
4
2019
65
0.640
Why?
Kidney Diseases
4
2014
239
0.640
Why?
Disability Evaluation
1
2019
211
0.630
Why?
Vaccination
2
2010
126
0.610
Why?
Apolipoproteins
3
2014
197
0.600
Why?
JC Virus
2
2014
23
0.590
Why?
Tumor Virus Infections
2
2014
20
0.590
Why?
Activities of Daily Living
4
2009
240
0.590
Why?
Polyomavirus Infections
2
2014
21
0.590
Why?
Lipoproteins, HDL
3
2014
247
0.590
Why?
Pneumonia, Bacterial
3
2005
31
0.570
Why?
Thoracostomy
1
2016
4
0.570
Why?
Pneumothorax
1
2016
8
0.560
Why?
Research
4
2010
72
0.550
Why?
Internal Medicine
4
2006
45
0.540
Why?
Transcription Factors
2
2009
174
0.520
Why?
Comorbidity
8
2015
548
0.510
Why?
Inflammation
2
2012
510
0.510
Why?
Pneumonia
2
2005
62
0.500
Why?
Female
28
2019
18304
0.480
Why?
Aging, Premature
1
2013
3
0.470
Why?
Cytokines
2
2012
243
0.470
Why?
Aged, 80 and over
12
2019
3733
0.470
Why?
Anti-Infective Agents
3
2015
43
0.470
Why?
Male
26
2019
17930
0.470
Why?
Physical Fitness
2
2012
120
0.470
Why?
United States
14
2017
3673
0.460
Why?
T-Lymphocytes
3
2013
116
0.460
Why?
Wounds and Injuries
1
2016
251
0.460
Why?
Chronic Disease
6
2016
370
0.450
Why?
Middle Aged
17
2016
10913
0.450
Why?
Diabetes Complications
1
2014
171
0.450
Why?
Bacterial Translocation
1
2012
8
0.440
Why?
Acute-Phase Proteins
1
2012
10
0.440
Why?
Membrane Glycoproteins
2
2012
97
0.430
Why?
Models, Immunological
1
2012
10
0.430
Why?
Panax
1
2012
8
0.420
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2012
17
0.410
Why?
Health Services Research
1
2012
79
0.410
Why?
Virus Diseases
2
2012
19
0.410
Why?
Medicine
4
2017
30
0.410
Why?
Carrier Proteins
1
2012
131
0.400
Why?
B-Lymphocytes
3
2010
71
0.400
Why?
Plant Extracts
1
2012
60
0.400
Why?
Models, Biological
1
2013
373
0.400
Why?
Idiopathic Pulmonary Fibrosis
1
2010
6
0.380
Why?
Health Priorities
1
2010
14
0.380
Why?
Adult
15
2016
8503
0.370
Why?
Dinoprostone
1
2010
37
0.370
Why?
Clostridium difficile
3
2016
12
0.370
Why?
Evidence-Based Practice
1
2010
25
0.360
Why?
African Americans
2
2014
1373
0.360
Why?
Interleukin-12
3
2014
26
0.350
Why?
Acute Disease
2
2012
239
0.350
Why?
Herpes Zoster Vaccine
1
2009
4
0.350
Why?
Interleukin-23 Subunit p19
1
2009
10
0.350
Why?
Transportation of Patients
2
2009
21
0.350
Why?
Histones
1
2009
49
0.340
Why?
Homes for the Aged
1
2009
19
0.340
Why?
Patient Care Management
1
2009
17
0.340
Why?
Nursing Homes
1
2009
42
0.330
Why?
Antibodies, Bacterial
2
2013
31
0.330
Why?
Cross Infection
1
2009
46
0.330
Why?
Risk Factors
10
2016
3588
0.330
Why?
Cytomegalovirus Infections
4
2013
25
0.320
Why?
Herpesvirus Vaccines
1
2007
1
0.310
Why?
Animals
13
2015
7328
0.310
Why?
Herpesvirus 3, Human
1
2007
3
0.310
Why?
Brucella abortus
1
2007
2
0.310
Why?
Brucellosis
1
2007
5
0.310
Why?
Viral Vaccines
1
2007
13
0.300
Why?
Home Infusion Therapy
1
2007
1
0.300
Why?
Home Care Services, Hospital-Based
1
2007
3
0.300
Why?
Immunization
1
2007
28
0.300
Why?
Cardiovascular Diseases
2
2014
1052
0.300
Why?
Patient Acceptance of Health Care
1
2009
156
0.300
Why?
Neuralgia
1
2007
48
0.290
Why?
Health Services Accessibility
1
2009
231
0.290
Why?
Congresses as Topic
4
2019
37
0.290
Why?
Gene Expression Regulation
1
2009
481
0.280
Why?
Specialization
3
2019
30
0.280
Why?
Hematopoietic Stem Cell Transplantation
2
2007
83
0.280
Why?
Apoptosis
4
2006
337
0.280
Why?
Antigens, Surface
1
2005
19
0.270
Why?
Individuality
1
2005
5
0.270
Why?
Mice
7
2015
2383
0.270
Why?
Prognosis
6
2013
1367
0.270
Why?
Spleen
1
2005
82
0.260
Why?
Hospitals, University
1
2005
23
0.260
Why?
Immunologic Factors
1
2005
48
0.260
Why?
Skin Ulcer
2
2015
10
0.260
Why?
Clostridium Infections
2
2016
9
0.260
Why?
Malnutrition
1
2005
17
0.260
Why?
Trauma Centers
1
2005
88
0.250
Why?
Influenza Vaccines
3
2014
79
0.250
Why?
Long-Term Care
4
2014
21
0.250
Why?
Health Status Indicators
1
2004
67
0.250
Why?
Prostaglandin D2
2
2005
4
0.240
Why?
Hepatitis C, Chronic
2
2015
77
0.240
Why?
Postural Balance
1
2016
159
0.240
Why?
Cognition
2
2005
526
0.240
Why?
Anti-Bacterial Agents
3
2013
286
0.230
Why?
Pesticides
1
2016
188
0.230
Why?
Occupational Exposure
1
2016
223
0.220
Why?
alpha-Tocopherol
1
2002
1
0.220
Why?
Mucous Membrane
1
2002
20
0.220
Why?
Vitamin A
1
2002
19
0.220
Why?
Emigrants and Immigrants
1
2016
234
0.220
Why?
Receptors, Cytoplasmic and Nuclear
1
2002
14
0.220
Why?
Awards and Prizes
1
2002
11
0.220
Why?
Transients and Migrants
1
2016
280
0.220
Why?
Incidence
4
2012
1124
0.210
Why?
Hematologic Neoplasms
1
2002
28
0.210
Why?
Academic Medical Centers
1
2002
150
0.200
Why?
Young Adult
4
2016
2422
0.200
Why?
Age Factors
6
2015
1116
0.190
Why?
Stem Cell Transplantation
1
2002
203
0.190
Why?
Intubation, Intratracheal
2
2019
71
0.190
Why?
Health Services Needs and Demand
2
2012
67
0.190
Why?
Education, Medical
2
2019
68
0.180
Why?
Attitude of Health Personnel
1
2002
163
0.180
Why?
Treatment Outcome
6
2016
3119
0.180
Why?
Evidence-Based Medicine
2
2014
208
0.180
Why?
Linear Models
4
2015
427
0.180
Why?
Staff Development
1
2019
13
0.180
Why?
Breast Neoplasms
2
2002
673
0.180
Why?
Hispanic Americans
1
2016
903
0.170
Why?
Mice, Inbred C57BL
3
2013
713
0.170
Why?
Continuous Positive Airway Pressure
1
2019
6
0.170
Why?
Teaching
1
2019
55
0.170
Why?
Up-Regulation
2
2010
183
0.170
Why?
Mentors
1
2019
29
0.170
Why?
Faculty, Medical
1
2019
69
0.170
Why?
Age Distribution
3
2013
199
0.170
Why?
Physical Therapy Modalities
1
2019
60
0.170
Why?
Leadership
1
2019
34
0.170
Why?
Immunity, Innate
2
2016
64
0.160
Why?
Adolescent
4
2016
3273
0.150
Why?
Mobility Limitation
1
2019
187
0.150
Why?
PPAR gamma
2
2015
45
0.150
Why?
Safety
2
2009
73
0.150
Why?
Career Mobility
1
2017
14
0.150
Why?
Severity of Illness Index
4
2015
864
0.150
Why?
Wound Healing
2
2015
186
0.140
Why?
Mice, Inbred DBA
2
2007
36
0.140
Why?
Acquired Immunodeficiency Syndrome
1
2016
17
0.140
Why?
Kidney Failure, Chronic
2
2012
522
0.140
Why?
Empyema
1
2016
1
0.140
Why?
Chest Tubes
1
2016
6
0.140
Why?
Cardiopulmonary Resuscitation
1
2016
23
0.140
Why?
Arachidonic Acid
2
2006
35
0.140
Why?
Lymphocyte Count
2
2005
23
0.140
Why?
Cell Survival
4
2010
274
0.130
Why?
Morbidity
2
2007
92
0.130
Why?
Forecasting
3
2015
133
0.130
Why?
PPAR alpha
1
2015
29
0.130
Why?
Surgical Wound Infection
1
2016
74
0.130
Why?
Mice, Inbred BALB C
3
2014
160
0.130
Why?
Aviation
1
2015
1
0.130
Why?
Electric Stimulation Therapy
1
2015
18
0.130
Why?
CD8-Positive T-Lymphocytes
2
2005
93
0.130
Why?
Retrospective Studies
4
2016
3134
0.120
Why?
Negative-Pressure Wound Therapy
1
2015
43
0.120
Why?
Adaptive Immunity
2
2013
14
0.120
Why?
Double-Blind Method
2
2013
504
0.120
Why?
Digestive System
1
2013
3
0.120
Why?
Hyperglycemia
1
2014
82
0.120
Why?
Influenzavirus A
1
2013
1
0.120
Why?
Multivariate Analysis
2
2012
638
0.120
Why?
Population Groups
1
2013
7
0.120
Why?
Virion
1
2013
10
0.120
Why?
Central Nervous System Neoplasms
1
2014
28
0.120
Why?
Adjuvants, Immunologic
1
2014
51
0.120
Why?
RNA, Messenger
1
2015
520
0.120
Why?
Patient Care
1
2014
33
0.120
Why?
Mass Vaccination
1
2013
7
0.120
Why?
Eye
1
2013
15
0.120
Why?
Pneumonia, Pneumococcal
1
2013
12
0.120
Why?
Societies, Medical
3
2017
150
0.120
Why?
B-Lymphocyte Subsets
1
2013
18
0.110
Why?
Pneumococcal Vaccines
1
2013
25
0.110
Why?
Diabetes Mellitus
1
2016
376
0.110
Why?
Hepatitis B Vaccines
1
2013
10
0.110
Why?
Enterocolitis, Pseudomembranous
1
2013
7
0.110
Why?
Hepatitis B
1
2013
15
0.110
Why?
Gene Expression Regulation, Neoplastic
2
2006
249
0.110
Why?
Bile Duct Diseases
1
2013
9
0.110
Why?
Glioma
1
2014
133
0.110
Why?
Polypharmacy
1
2012
20
0.110
Why?
Program Development
2
2019
85
0.110
Why?
Hand Strength
1
2012
86
0.110
Why?
Cross-Sectional Studies
2
2015
1376
0.100
Why?
Osteoarthritis
1
2013
74
0.100
Why?
Needs Assessment
1
2012
68
0.100
Why?
Influenza, Human
1
2013
123
0.100
Why?
Disease Models, Animal
2
2014
983
0.100
Why?
Inflammation Mediators
1
2012
101
0.100
Why?
Bone Marrow Cells
2
2010
115
0.100
Why?
Anti-HIV Agents
1
2012
54
0.100
Why?
Muscle Fibers, Skeletal
1
2012
104
0.100
Why?
Gait
1
2012
115
0.100
Why?
Exercise Test
1
2012
194
0.100
Why?
Blood Glucose
1
2014
469
0.100
Why?
Survival Rate
2
2005
796
0.100
Why?
Membrane Proteins
1
2013
256
0.100
Why?
Postoperative Complications
1
2016
673
0.100
Why?
Sensitivity and Specificity
1
2012
533
0.100
Why?
African Continental Ancestry Group
1
2012
350
0.100
Why?
Practice Guidelines as Topic
1
2014
375
0.100
Why?
Genetic Variation
1
2012
251
0.100
Why?
Promoter Regions, Genetic
2
2009
213
0.100
Why?
CD4-Positive T-Lymphocytes
2
2013
47
0.090
Why?
Toll-Like Receptor 8
1
2010
5
0.090
Why?
Flow Cytometry
3
2005
172
0.090
Why?
Receptors, Prostaglandin E
1
2010
4
0.090
Why?
Shoulder Joint
1
2013
123
0.090
Why?
Toll-Like Receptor 7
1
2010
11
0.090
Why?
Health Planning Guidelines
1
2010
5
0.090
Why?
Creatinine
1
2011
175
0.090
Why?
Motor Activity
1
2013
311
0.090
Why?
Antigen-Presenting Cells
1
2010
6
0.090
Why?
Telomere
1
2010
10
0.090
Why?
Neoplasms
1
2016
620
0.090
Why?
Signal Transduction
2
2013
669
0.090
Why?
Immunization Schedule
1
2010
24
0.090
Why?
Toll-Like Receptor 4
1
2010
41
0.090
Why?
Transforming Growth Factor beta
1
2010
66
0.090
Why?
Syndrome
2
2013
66
0.090
Why?
Proto-Oncogene Proteins c-rel
1
2009
1
0.090
Why?
Nurses
1
2009
14
0.090
Why?
Chromatin
1
2009
20
0.090
Why?
Interleukin-6
1
2010
225
0.090
Why?
Tissue Engineering
1
2015
617
0.090
Why?
Nursing Diagnosis
1
2009
2
0.090
Why?
Time Factors
3
2004
2010
0.090
Why?
Triazenes
2
2006
4
0.090
Why?
Body Temperature
1
2009
22
0.090
Why?
Diagnostic Tests, Routine
1
2009
23
0.090
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
152
0.080
Why?
Disease Outbreaks
1
2009
35
0.080
Why?
Interdisciplinary Communication
1
2009
53
0.080
Why?
Physical Examination
1
2009
82
0.080
Why?
Metabolic Diseases
1
2008
17
0.080
Why?
Analysis of Variance
2
2015
454
0.080
Why?
Immunity
1
2008
20
0.080
Why?
Antiretroviral Therapy, Highly Active
1
2008
29
0.080
Why?
HIV-1
1
2008
45
0.080
Why?
Physician Assistants
1
2009
41
0.080
Why?
Liver Diseases
1
2008
62
0.080
Why?
Aspergillosis
1
2007
4
0.080
Why?
Lymphocyte Depletion
1
2007
14
0.080
Why?
Muscle, Skeletal
1
2012
494
0.080
Why?
Opportunistic Infections
1
2007
9
0.080
Why?
Health Services for the Aged
1
2007
25
0.080
Why?
Th1 Cells
1
2007
18
0.080
Why?
Bone Marrow Transplantation
1
2007
65
0.080
Why?
Superoxide Dismutase
1
2007
47
0.080
Why?
Infusions, Intravenous
1
2007
85
0.070
Why?
Immunoglobulin G
1
2007
105
0.070
Why?
Education, Medical, Continuing
2
2006
45
0.070
Why?
Liver
3
2015
464
0.070
Why?
North Carolina
2
2016
1426
0.070
Why?
Antigens, CD
2
2004
100
0.070
Why?
Risk Assessment
3
2012
1324
0.070
Why?
Program Evaluation
1
2006
175
0.070
Why?
Transcription, Genetic
2
2006
137
0.070
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2005
20
0.070
Why?
Receptors, IgG
1
2005
7
0.070
Why?
Drug Resistance, Microbial
1
2005
11
0.070
Why?
Nitrobenzenes
1
2005
10
0.070
Why?
Receptors, Eicosanoid
1
2005
3
0.070
Why?
Renal Insufficiency, Chronic
1
2009
272
0.070
Why?
Immunologic Memory
1
2005
31
0.070
Why?
Colonic Neoplasms
1
2006
63
0.070
Why?
Arachidonic Acids
1
2005
23
0.070
Why?
Chronology as Topic
1
2005
1
0.070
Why?
Emergency Medical Service Communication Systems
1
2005
3
0.070
Why?
Clinical Competence
2
2005
308
0.070
Why?
Organophosphorus Compounds
1
2005
35
0.070
Why?
Emergency Medical Technicians
1
2005
11
0.070
Why?
Statistics as Topic
1
2005
107
0.070
Why?
Tennessee
1
2005
97
0.070
Why?
Sulfonamides
1
2005
65
0.070
Why?
Imidazoles
1
2005
104
0.060
Why?
Neutrophils
1
2005
102
0.060
Why?
Research Design
2
2006
287
0.060
Why?
Nutrition Assessment
1
2005
54
0.060
Why?
Disease Susceptibility
2
2016
53
0.060
Why?
Sex Distribution
1
2005
187
0.060
Why?
Cytomegalovirus
1
2004
20
0.060
Why?
Drug Therapy, Combination
1
2005
273
0.060
Why?
Phenotype
3
2013
633
0.060
Why?
Hematopoiesis
1
2004
34
0.060
Why?
Models, Theoretical
1
2005
131
0.060
Why?
Familial Mediterranean Fever
1
2003
2
0.060
Why?
Genetic Heterogeneity
1
2003
13
0.060
Why?
Periodicity
1
2003
10
0.060
Why?
Population Dynamics
1
2003
5
0.060
Why?
Case-Control Studies
1
2016
861
0.060
Why?
Hematopoietic Stem Cells
1
2004
95
0.060
Why?
Receptors, Tumor Necrosis Factor
1
2003
45
0.060
Why?
Retirement
1
2003
11
0.060
Why?
Biopsy
2
2015
241
0.060
Why?
Reproducibility of Results
1
2005
727
0.060
Why?
Tocopherols
1
2002
3
0.060
Why?
Cell Proliferation
1
2005
574
0.060
Why?
Mortality
1
2004
112
0.060
Why?
Training Support
1
2002
5
0.060
Why?
Response Elements
1
2002
16
0.060
Why?
Research Support as Topic
1
2002
25
0.050
Why?
Fluoroquinolones
1
2002
10
0.050
Why?
Protein Transport
1
2002
75
0.050
Why?
Fluorescent Antibody Technique
1
2002
85
0.050
Why?
Leukemia
1
2002
37
0.050
Why?
Lymphoma
1
2002
36
0.050
Why?
Demography
1
2002
104
0.050
Why?
Developing Countries
1
2002
43
0.050
Why?
Tumor Cells, Cultured
1
2002
159
0.050
Why?
Transplantation Conditioning
1
2002
11
0.050
Why?
Health Status
1
2004
370
0.050
Why?
Chi-Square Distribution
2
2013
293
0.050
Why?
Child
1
2008
2227
0.050
Why?
Cell Nucleus
1
2002
109
0.050
Why?
Residence Characteristics
1
2003
181
0.050
Why?
Glomerular Filtration Rate
2
2013
289
0.050
Why?
Albuminuria
2
2013
177
0.050
Why?
Depression
1
2004
386
0.050
Why?
Data Collection
1
2002
163
0.050
Why?
Educational Status
1
2002
165
0.050
Why?
Physicians
1
2003
135
0.050
Why?
Diagnosis, Differential
1
2002
493
0.050
Why?
Disease Progression
2
2015
574
0.050
Why?
Video Recording
1
2019
52
0.040
Why?
Genetic Predisposition to Disease
2
2013
839
0.040
Why?
Respiration, Artificial
1
2019
96
0.040
Why?
Pedigree
2
2012
133
0.040
Why?
Curriculum
1
2019
197
0.040
Why?
Host-Pathogen Interactions
1
2016
31
0.030
Why?
Caspases
2
2005
31
0.030
Why?
Caspase 3
2
2005
30
0.030
Why?
Liver Cirrhosis
1
2015
75
0.030
Why?
Reference Values
1
2015
224
0.030
Why?
Canada
1
2015
49
0.030
Why?
Tracheostomy
1
2015
28
0.030
Why?
Administration, Topical
1
2015
130
0.030
Why?
Immunity, Mucosal
1
2014
5
0.030
Why?
Immunoglobulin A
1
2014
9
0.030
Why?
Influenza A Virus, H3N2 Subtype
1
2014
22
0.030
Why?
Influenza B virus
1
2014
20
0.030
Why?
Orthomyxoviridae Infections
1
2014
20
0.030
Why?
Vaccines, Inactivated
1
2014
37
0.030
Why?
Viral Load
1
2014
67
0.030
Why?
Antibodies, Viral
1
2014
57
0.030
Why?
Immunity, Active
1
2013
1
0.030
Why?
Polysaccharides, Bacterial
1
2013
10
0.030
Why?
Transgenes
1
2013
45
0.030
Why?
Immunity, Humoral
1
2013
12
0.030
Why?
Immunomodulation
1
2013
30
0.030
Why?
Regression Analysis
1
2014
274
0.030
Why?
Hepatitis B Antibodies
1
2013
1
0.030
Why?
Cystatin C
1
2013
28
0.030
Why?
Nonlinear Dynamics
1
2013
52
0.030
Why?
Cell Line, Tumor
2
2005
684
0.030
Why?
DNA, Viral
1
2013
47
0.030
Why?
Interleukin-17
1
2013
14
0.030
Why?
Liver Cirrhosis, Biliary
1
2013
6
0.030
Why?
Jaundice
1
2013
4
0.030
Why?
Gene Expression
2
2005
334
0.030
Why?
Cholestasis
1
2013
18
0.030
Why?
Disease Management
1
2014
114
0.030
Why?
Anti-Retroviral Agents
1
2013
21
0.030
Why?
Isotonic Contraction
1
2012
8
0.030
Why?
Myofibrils
1
2012
10
0.030
Why?
Secondary Prevention
1
2013
59
0.030
Why?
Length of Stay
1
2014
295
0.030
Why?
Heredity
1
2012
12
0.030
Why?
Physical Conditioning, Animal
1
2012
32
0.030
Why?
Pilot Projects
1
2014
483
0.030
Why?
Models, Animal
1
2013
161
0.030
Why?
Lung
1
2014
237
0.030
Why?
Muscular Atrophy
1
2012
67
0.030
Why?
Gene Frequency
1
2012
225
0.030
Why?
Myosin Heavy Chains
1
2012
86
0.030
Why?
Range of Motion, Articular
1
2013
177
0.030
Why?
Monocytes
1
2013
120
0.030
Why?
Hospitalization
1
2014
421
0.020
Why?
Prevalence
1
2013
910
0.020
Why?
Quality of Life
1
2015
825
0.020
Why?
Prospective Studies
1
2014
2040
0.020
Why?
Kidney
1
2012
487
0.020
Why?
Tomography, X-Ray Computed
1
2013
871
0.020
Why?
Cyclosporine
1
2007
34
0.020
Why?
Graft vs Host Disease
1
2007
18
0.020
Why?
Transplantation, Homologous
1
2007
113
0.020
Why?
Methotrexate
1
2007
60
0.020
Why?
Immunosuppression
1
2007
80
0.020
Why?
Certification
1
2006
25
0.020
Why?
Survival Analysis
1
2007
440
0.020
Why?
HCT116 Cells
1
2006
12
0.020
Why?
Proto-Oncogene Proteins c-jun
1
2006
6
0.020
Why?
Transcription Factor AP-1
1
2006
18
0.020
Why?
Immunosuppressive Agents
1
2007
167
0.020
Why?
Coenzyme A Ligases
1
2005
2
0.020
Why?
Acyltransferases
1
2005
16
0.020
Why?
Peroxisome Proliferator-Activated Receptors
1
2005
3
0.020
Why?
Hydroxyeicosatetraenoic Acids
1
2005
2
0.020
Why?
Anilides
1
2005
7
0.020
Why?
Interviews as Topic
1
2006
249
0.020
Why?
Pertussis Toxin
1
2005
16
0.020
Why?
Poly(ADP-ribose) Polymerases
1
2005
9
0.020
Why?
Mitosis
1
2005
22
0.020
Why?
Drug Synergism
1
2005
67
0.020
Why?
Hela Cells
1
2005
88
0.020
Why?
Binding Sites
1
2005
125
0.020
Why?
Protein Binding
1
2005
199
0.020
Why?
Transfection
1
2005
192
0.020
Why?
Organizational Objectives
1
2004
22
0.020
Why?
ADP-ribosyl Cyclase
1
2004
4
0.020
Why?
Cell Line
1
2005
455
0.020
Why?
Antigens, CD34
1
2004
54
0.020
Why?
Virus Replication
1
2004
53
0.010
Why?
Polymerase Chain Reaction
1
2004
173
0.010
Why?
Founder Effect
1
2003
4
0.010
Why?
Kinetics
1
2004
206
0.010
Why?
Receptors, Tumor Necrosis Factor, Type I
1
2003
14
0.010
Why?
Microsatellite Repeats
1
2003
25
0.010
Why?
Cohort Studies
1
2007
1699
0.010
Why?
Family Health
1
2003
78
0.010
Why?
Haplotypes
1
2003
220
0.010
Why?
Cell Culture Techniques
1
2004
165
0.010
Why?
Tissue Donors
1
2004
167
0.010
Why?
Probability
1
2002
150
0.010
Why?
Administration, Oral
1
2002
169
0.010
Why?
Drug Administration Schedule
1
2002
247
0.010
Why?
Dose-Response Relationship, Drug
1
2002
641
0.010
Why?
Follow-Up Studies
1
2002
2118
0.010
Why?
High's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (452)
Explore
_
Co-Authors (37)
Explore
_
Similar People (50)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_